ENTITY
Roche Holding

Roche Holding (RO SE)

55
Analysis
Health Care • United States
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system. Roche Holding serves customers worldwide.
more
bullish•Sixt SE
•19 Feb 2024 06:55

Liquid Universe of European Ordinary and Preferred Shares: February‘24 Report

Since mid-January, spreads have tightened, same as in December, across our European liquid universe of ordinary and preferred shares (13 have...

Share
bullish•Grifols SA
•16 Jan 2024 18:56

Liquid Universe of European Ordinary and Preferred Shares: January‘24 Report

Since mid-December, spreads have generally tightened across our European liquid universe of ordinary and preferred shares. The spread of Grifols...

Share
bullish•Volkswagen (Pref)
•17 Nov 2023 02:56

Liquid Universe of European Ordinary and Preferred Shares: November‘23 Report

Since mid-October, spreads have generally widened across our European liquid universe of ordinary and preferred shares (8 have tightened, 10...

Share
bullish•WuXi XDC Cayman
•16 Nov 2023 08:09

WuXi XDC Cayman IPO Trading - Strong Subscription Rates Heading into Listing

WuXi XDC Cayman (1877628D HK) raised US$470m in its Hong Kong IPO. In our previous notes, we looked at the company’s past performance and...

Logo
592 Views
Share
bullish•WuXi XDC Cayman
•07 Nov 2023 11:39

WuXi XDC Cayman IPO - Decent Upside from IPO Range, Bulk of the Deal Taken up by Marquee Investors

WuXi XDC Cayman (1877628D HK) is looking to raise US$470m in its Hong Kong IPO. In this note, we will look at the deal dynamics and share our final...

Logo
758 Views
Share
x